Comparison of specificities between two interferon-gamma release assays in Japan

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 9, 2012, Pages 1190-1192

  Higuchi, Kazue ^a   Sekiya, Y ^a   Igari, H ^b,c   Watanabe, A ^b   Harada, N ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

IGRAs; Specificity; Tuberculosis

Indexed keywords

ACCURACY; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; JAPAN; MALE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; STUDENT RECRUITMENT;

ADULT; BCG VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; JAPAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULOSIS; YOUNG ADULT;

EID: 84865224793     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0829     Document Type: Article

References (12)

1. Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 2010; 28: 245-252.
2. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
3. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952-968.
4. Higuchi K, Kawabe Y, Mitarai S, Yoshiyama T, Harada N, Mori T. Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 2009; 198: 33-37.
5. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T-cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183: 469- 477.
6. Pathan A A, Wilkinson K A, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T-cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167: 5217-5225. (Pubitemid 33009758)
7. Lalvani A, Pathan A A, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of a ntigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-828. (Pubitemid 32275850)
8. Chapman A L, Munkanta M, Wilkinson K A, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosisspecific T-cells. AIDS 2002; 16: 2285-2293. (Pubitemid 35449014)
9. Detjen A K, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and non-tuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328. (Pubitemid 47101028)
10. Rangaka M X, Wilkinson K A, Glynn J R, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 45-55.
11. Harada N, Higuchi K, Sekiya Y, Rothel J, Kitoh T, Mori T. [Basic characteristics of a novel diagnostic method (Quanti- FERON® TB-2G) of latent tuberculosis infection with a use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10]. Kekkaku 2004; 79: 725-735. [Japanese]
12. Prevention Committee, Japanese Society of Tuberculosis. [Guidelines for the use of QuantiFERON® TB Gold]. Kekkaku 2011; 86: 839-844. [Japanese]